STAT3 and leukemia: In the largest study of γδT-LGL leukemia to date by Barilà et al., mutations in STAT3 were identified in 37 of 97 patients (38.1%) and mutations in STAT5B were detected in four of 94 patients (4.8%) (Barilà et al., 2023).